Biotech company Zogenix more than doubles after reporting strong results from a trial of an anti-seizure drug for a rare form of epilepsy. For more stories and …
source CNBC
Biotech company Zogenix more than doubles after reporting strong results from a trial of an anti-seizure drug for a rare form of epilepsy. For more stories and …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More